Trial Profile
Randomised, Double-blind, Multi-centre study to compare the the safety, tolerability, and immunogenicity of the refrigerator-stable formulation of the Varicella vaccine to that of the frozen formulation in Healthy children
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Sep 2018
Price :
$35
*
At a glance
- Drugs Varicella zoster virus vaccine live (Primary) ; Measles mumps and rubella virus vaccine
- Indications Varicella zoster virus infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Merck & Co
- 04 Sep 2018 New trial record
- 23 Aug 2018 Primary endpoint (Immune Response) has been met, according to the results published in the Vaccine.
- 23 Aug 2018 Results published in the Vaccine